Show source-provided references
2. O’Sullivan, B., Lydiatt, W.M., Haughey, B.H., Brandwein-Gensler, M., Glastonbury, C.M., Shah, J.P., Amin, M.B., Edge, S., and Greene, F. (2017). HPV-mediated (p16+) oropharyngeal cancer. AJCC Cancer Staging Manual, Springer. [8th ed.].
3. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: A two-tier approach
10.1038/s41416-019-0414-9 ↗4. Advances in Diagnosis and Multi-disciplinary Management of Oro-pharyngeal Squamous Cell Carci-noma
5. Imaging at Diagnosis Impacts Cancer Specific Survival of Patients with Cancer of the Oropharynx
10.1002/cncr.32148 ↗13. Radiomic analysis in prediction of Human Papilloma Virus status
14. Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: A multicenter study
10.1259/bjr.20170498 ↗15. Application of radiomics for the prediction of HPV status for patients with head and neck cancers
10.1002/mp.13977 ↗16. Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis
10.3389/fonc.2021.744250 ↗17. Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma
10.3174/ajnr.A4271 ↗18. Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma
10.1007/s00405-013-2641-7 ↗19. Oropharyngeal squamous cell carcinoma: Radiomic machine-learning classifiers from multiparametric MR images for determination of HPV infection status
10.1038/s41598-020-74479-x ↗20. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas
10.1002/hed.24051 ↗21. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
10.1038/bjc.2013.639 ↗22. Double Positivity for HPV-DNA/p16(Ink4a) is the Biomarker with Strongest Diagnostic Accuracy and Prognostic Value for Human Papillomavirus Related Oropharyngeal Cancer Patients
10.1016/j.oraloncology.2018.01.010 ↗25. Technical Note: An IBEX adaption toward image biomarker standardization
10.1002/mp.13956 ↗26. Ibex: An open infrastructure software platform to facilitate collaborative work in radiomics
10.1118/1.4908210 ↗27. Zwanenburg, A., Leger, S., Vallières, M., and Löck, S. (2020). Image biomarker standardisation initiative. arXiv.
28. Reliability of CT radiomic features reflecting tumour heterogeneity according to image quality and image processing parameters
10.1038/s41598-020-60868-9 ↗33. Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer
10.1002/hed.26505 ↗34. Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma
10.3174/ajnr.A5792 ↗35. Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status
10.1016/j.ejrad.2019.08.009 ↗36. Multiparametric functional MRI and 18F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
10.1007/s00330-020-07163-3 ↗37. Apparent Diffusion Coefficient Histograms of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology
10.3174/ajnr.A5370 ↗40. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and elaboration
10.7326/M14-0698 ↗